Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ian M. Paul, Kate M. Reynolds, Ralph E. Kauffman, William Banner, G. Randall Bond, Robert B. Palmer, Randy I. Burnham & Jody L. Green. (2017) Adverse events associated with pediatric exposures to dextromethorphan. Clinical Toxicology 55:1, pages 25-32.
Read now
Read now
Jack J. Chen. (2011) Pharmacologic Safety Concerns in Parkinson's Disease: Facts and Insights. International Journal of Neuroscience 121:sup2, pages 45-52.
Read now
Read now
Matthew D. Wilson, Rennie W. Ferguson, Maryann E. Mazer & Toby L. Litovitz. (2011) Monitoring trends in dextromethorphan abuse using the National Poison Data System: 2000–2010. Clinical Toxicology 49:5, pages 409-415.
Read now
Read now
SarahC. Akerman, JohnL. Hammel & MaryF. Brunette. (2010) Dextromethorphan Abuse and Dependence in Adolescents. Journal of Dual Diagnosis 6:3-4, pages 266-278.
Read now
Read now
Articles from other publishers (45)
Priyanka Pravinbhai Hotha, Rachna Gupta & Manish Narang. (2023) Dextromethorphan-Induced Altered Level of Consciousness in Children:
A Case Series. Current Drug Safety 18:3, pages 389-392.
Crossref
Crossref
Dicson S. Malar, Premrutai Thitilertdecha, Kanokphorn S. Ruckvongacheep, Sirikalaya Brimson, Tewin Tencomnao & James M. Brimson. (2023) Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders. CNS Drugs 37:5, pages 399-440.
Crossref
Crossref
Ian A. Jones, Amit S. Piple, Pui Yuk Yan, Donald B. Longjohn, Paul K. Gilbert, Jay R. Lieberman, Gligor V. Gucev, Daniel A. Oakes, Christina E. Ratto, Alexander B. Christ & Nathanael D. Heckmann. (2023) A double-blinded, placebo-controlled, randomized study to evaluate the efficacy of perioperative dextromethorphan compared to placebo for the treatment of postoperative pain: a study protocol. Trials 24:1.
Crossref
Crossref
Malgorzata Zaremba, Pawel Serafin & Patrycja Kleczkowska. (2023) Antipsychotic Drugs Efficacy in Dextromethorphan-Induced Psychosis. Biomedicines 11:1, pages 123.
Crossref
Crossref
Anthony Spadaro, Kevin R. Scott, Alex Koyfman & Brit Long. (2022) High risk and low prevalence diseases: Serotonin syndrome. The American Journal of Emergency Medicine 61, pages 90-97.
Crossref
Crossref
Igor Elman, Amanda Pustilnik & David Borsook. (2022) Beating pain with psychedelics: Matter over mind?. Neuroscience & Biobehavioral Reviews 134, pages 104482.
Crossref
Crossref
Mark Forrest Gordon, Adena N. Leder & Laura A. Ketigian. 2022. Movement Disorder Emergencies. Movement Disorder Emergencies
139
169
.
Roudi Bachar, John Robert Majewski, Christopher Shrack & Anthony El-Khoury. (2021) Acute psychosis and serotonin syndrome in the setting of “Triple-C” overdose: a case report. Journal of Medical Case Reports 15:1.
Crossref
Crossref
Anand K. Gavai, Yamine Bouzembrak, Leonieke M. van den Bulk, Ningjing Liu, Lennert F.D. van Overbeeke, Lukas J. van den Heuvel, Hans Mol & Hans J.P. Marvin. (2021) Artificial intelligence to detect unknown stimulants from scientific literature and media reports. Food Control 130, pages 108360.
Crossref
Crossref
Eun-Joo Shin, Ji Hoon Jeong, Bao-Trong Nguyen, Naveen Sharma, Seung-Yeol Nah, Yoon Hee Chung, Yi Lee, Jae Kyung Byun, Toshitaka Nabeshima, Sung Kwon Ko & Hyoung-Chun Kim. (2021) Ginsenoside Re Protects against Serotonergic Behaviors Evoked by 2,5-Dimethoxy-4-iodo-amphetamine in Mice via Inhibition of PKCδ-Mediated Mitochondrial Dysfunction. International Journal of Molecular Sciences 22:13, pages 7219.
Crossref
Crossref
Rosalind Gittins, Louise Missen & Ian Maidment. (2021) Misuse of medication in adult substance misuse services: a systematic review protocol. BMJ Open 11:6, pages e047283.
Crossref
Crossref
Pierre-Louis Declercq, Jean-Pierre Eraldi, Marion Beuzelin, Stéphanie Gélinotte, Antoine Marchalot, François Bougerol, Delphine Allorge, Marie-Anne Loriot, Nicolas Paret, Bruno Mégarbane & Jean-Philippe Rigaud. (2021) Severe serotonin syndrome caused by an interaction between an antidepressant and a cough syrup. Therapies 76:3, pages 249-252.
Crossref
Crossref
G. Skopp. (2020) Serotonintoxizität – SerotoninsyndromSerotonin toxicity—serotonin syndrome. Notfall + Rettungsmedizin 23:1, pages 61-71.
Crossref
Crossref
G. Skopp. (2019) Serotonintoxizität – SerotoninsyndromSerotonin toxicity—serotonin syndrome. Rechtsmedizin 29:6, pages 511-522.
Crossref
Crossref
Masoud Seddighfar, Zahra Ghasemzadeh & Ameneh Rezayof. (2019) The blockade of 5-HT1A receptors in the ventral tegmental area inhibited morphine/dextromethorphan-induced analgesia in pain rat models. Brain Research 1715, pages 27-34.
Crossref
Crossref
Michael A. Emery & Shoshana Eitan. (2019) Members of the same pharmacological family are not alike: Different opioids, different consequences, hope for the opioid crisis?. Progress in Neuro-Psychopharmacology and Biological Psychiatry 92, pages 428-449.
Crossref
Crossref
David C. Sheridan, Robert G. Hendrickson, Gillian Beauchamp, Amber Laurie, Rongwei Fu & B. Zane Horowitz. (2019) Adolescent Intentional Abuse Ingestions. Pediatric Emergency Care 35:3, pages 176-179.
Crossref
Crossref
Michael Ott, Julie K. Mannchen, Fariba Jamshidi & Ursula Werneke. (2019) Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques. Therapeutic Advances in Psychopharmacology 9, pages 204512531881881.
Crossref
Crossref
Brian A. Baldo. (2018) Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects. Archives of Toxicology 92:8, pages 2457-2473.
Crossref
Crossref
M. Hahn & S. C. Roll. (2017) Validierung von Interaktionsdatenbanken in der PsychopharmakotherapieValidation of interaction databases in psychopharmacotherapy. Der Nervenarzt 89:3, pages 319-326.
Crossref
Crossref
Anna Rickli, Evangelia Liakoni, Marius C Hoener & Matthias E Liechti. (2018)
Opioid-induced inhibition of the human 5-HT and noradrenaline transporters
in vitro
: link to clinical reports of serotonin syndrome
. British Journal of Pharmacology 175:3, pages 532-543.
Crossref
Crossref
Andréia Cristina Karklin Fontana. 2018. Biochemical Approaches for Glutamatergic Neurotransmission. Biochemical Approaches for Glutamatergic Neurotransmission
169
225
.
Elizabeth Quaal Hines. (2017) Pediatric Poisonings: The Risk of Over-the-Counter Pharmaceuticals. Pediatric Annals 46:12.
Crossref
Crossref
Prudence Dy, Victor Arcega, Wael Ghali & Winifred Wolfe. (2017) Serotonin syndrome caused by drug to drug interaction between escitalopram and dextromethorphan. BMJ Case Reports, pages bcr-2017-221486.
Crossref
Crossref
S.J. Traub & M.D. Levine. 2017. Critical Care Neurology Part II. Critical Care Neurology Part II
485
505
.
Scott Lucyk & Lewis S. Nelson. 2017. Critical Care Toxicology. Critical Care Toxicology
1237
1249
.
Sachin Mane. (2016) Racemic drug resolution: a comprehensive guide. Analytical Methods 8:42, pages 7567-7586.
Crossref
Crossref
Scott Lucyk & Lewis S. Nelson. 2016. Critical Care Toxicology. Critical Care Toxicology
1
14
.
Scott Lucyk & Lewis S. Nelson. 2016. Critical Care Toxicology. Critical Care Toxicology
1
13
.
Steven Karch & Olaf Drummer. 2015. Karch's Pathology of Drug Abuse, Fifth Edition. Karch's Pathology of Drug Abuse, Fifth Edition
697
754
.
Aleksandra Piątek, Małgorzata Koziarska-Rościszewska & Jolanta B. Zawilska. (2015) Rekreacyjne używanie leków dostępnych w odręcznej sprzedaży: odurzanie i doping mózgu. Alcoholism and Drug Addiction 28:1, pages 65-77.
Crossref
Crossref
Scott Lucyk & Lewis S. Nelson. 2016. Critical Care Toxicology. Critical Care Toxicology
1
13
.
Suzanne Franki & Sarah B. Johnson. (2014) Trends and Treatment of Adolescent Street Drug Use. Child and Adolescent Psychopharmacology News 19:3, pages 5-8.
Crossref
Crossref
Janice E. Sullivan & Mark J. McDonald. 2014. Pediatric Critical Care Medicine. Pediatric Critical Care Medicine
695
727
.
Dhruv Modi, Ravikumar Bhalavat & James C. Patterson. (2013) Suicidal and Homicidal Behaviors Related to Dextromethorphan Abuse in a Middle-Aged Woman. Journal of Addiction Medicine 7:2, pages 143-144.
Crossref
Crossref
Stephen Thornton & Binh T. Ly. 2013. Emergency Medicine. Emergency Medicine
1334
1342.e1
.
Mark Forrest Gordon & Adena N. Leder. 2013. Movement Disorder Emergencies. Movement Disorder Emergencies
217
239
.
Virginia Melis, Iris Usach & José‐Esteban Peris. (2012)
Determination of sertraline in rat plasma by
HPLC
and fluorescence detection and its application to
in vivo
pharmacokinetic studies
. Journal of Separation Science 35:23, pages 3302-3307.
Crossref
Crossref
Donald G. Barceloux. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
527
538
.
Kerri A. Schoedel, Laura E. Pope & Edward M. Sellers. (2012) Randomized Open-Label Drug-Drug Interaction Trial of Dextromethorphan/Quinidine and Paroxetine in Healthy Volunteers. Clinical Drug Investigation 32:3, pages 157-169.
Crossref
Crossref
Mojdeh Mozayani. 2012. Handbook of Drug Interactions. Handbook of Drug Interactions
215
227
.
Rahul Rastogi, Robert A. Swarm & Trusharth A. Patel. (2011) Case Scenario. Anesthesiology 115:6, pages 1291-1298.
Crossref
Crossref
Daniel E. Brooks, Michael Levine, Ayrn D. O'Connor, Robert N.E. French & Steven C. Curry. (2011) Toxicology in the ICU. Chest 140:4, pages 1072-1085.
Crossref
Crossref
Antonio Drago, Concetta Crisafulli, Antonina Sidoti & Alessandro Serretti. (2011) The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes. Progress in Neurobiology 94:4, pages 418-460.
Crossref
Crossref
Andrew A. Monte, Ryan Chuang & Michael Bodmer. (2010) Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review. British Journal of Clinical Pharmacology 70:6, pages 794-798.
Crossref
Crossref